- 2022 - 2025 癌特異的EVs内のmiRNAをターゲットとした腫瘍免疫システムの機序解明
- 2022 - 2025 硼素中性子捕捉療法とLAT1を介した化学療法を併用する子宮頸癌の新たな治療戦略
- 2022 - 2025 卵巣癌再発・転移に対して硼素中性子捕捉療法の有用性の検討
- 2021 - 2024 卵巣癌オルガノイドを用いた脂肪細胞によるがん浸潤・転移機構の解明
- 2020 - 2023 3次元オルガノイド培養を用いた難治性卵巣癌の個別化医療の構築
- 2019 - 2023 複合的癌免疫治療による子宮頚癌治療の革新的開発
- 2018 - 2021 Target therapy of ovarian cancer including immunotherapy via Eribulin
- 2017 - 2020 Treatment strategy of boron neutron capture therapy in cervical cancer
- 2017 - 2020 Development of a new therapy for refractory ovarian cancer via liposomal nanoparticle targeting control of EMT
- 2017 - 2020 Research for cancer microenvironment via FABP4 in endometrial cnacer
- 2016 - 2019 A novel approach for cervical cancer using exosome
- 2016 - 2019 activation regulatory mechanism of cancer fibroblast by obesity
- 2016 - 2019 A novel miRNA regulates the EMT and MMT of peritoneal mesothelium in ovarian cancer
- 2015 - 2018 GPR30 signaling regulates Epithelial-Mesenchymal Transition in ovarian cancer
- 2015 - 2018 Testosterone for the Prevention of Cyclophosphamide -Induced Ovarian Toxicity
- 2014 - 2017 The elucidation of the mechanism in cancer microenvironment by ovarian cancer secretion exosome and the development of a next-generation cancer therapy by the exosome.
Show all
